The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
Open accessAbstract
Tumor-associated macrophages (TAMs) play a central role in tumor progression, metastasis, and recurrence after treatment. Macrophage plasticity and diversity allow their classification along a M1-M2 polarization axis. Tumor-associated macrophages usually display a M2-like phenotype, associated with pro-tumoral features whereas M1 macrophages exert antitumor functions. Targeting the reprogramming of TAMs toward M1-like macrophages would thus be an efficient way to promote tumor regression. This can be achieved through therapies including chemotherapy, immunotherapy, and radiotherapy (RT). In this review, we first describe how chemo- and immunotherapies can target TAMs and, second, we detail how RT modifies macrophage phenotype and present the molecular pathways that may be involved. The identification of irradiation dose inducing macrophage reprogramming and of the underlying mechanisms could lead to the design of novel therapeutic strategies and improve synergy in combined treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“In response to microbial signals, tissue damage, cytokines and metabolic products, monocytes, and macrophages from healthy tissues are able to undergo reprogramming (12, 21, 26, 27).”
BackgroundMicroenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878 · cited 10×
“C motif chemokine 12; ECM, extracellular matrix; ERK, extracellular signal-regulated kinase, FDA, food and drug administration; FRβ, folate receptor β; HDI, high doses of irradiation; HIF, hypoxiainducible factor; HLA-DR, human leukocyte antigen-cell surface receptor; HO1, heme oxygenase 1; HRG, histidine-rich glycopr…”
BackgroundInfluentialInterferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Zhu, Y., Knolhoff, B. L., Meyer, M. A., Nywening, T. M., West, B. L., Luo, J., Wang-Gillam, A., Goedegebuure, S. P., Linehan, D. C., & DeNardo, D. G. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3723 · Cited by 1,324
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206870 · Cited by 1,324
PI3Kγ is a molecular switch that controls immune suppression
Kaneda, M. M., Messer, K. S., Ralainirina, N., Li, H., Leem, C. J., Gorjestani, S., Woo, G., Nguyen, A. V., Figueiredo, C. C., Foubert, P., et al. (2016) · Nature · doi:10.1038/nature19834 · Cited by 1,173
Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Germano, G., Frapolli, R., Belgiovine, C., Anselmo, A., Pesce, S., Liguori, M., Erba, E., Uboldi, S., Zucchetti, M., Pasqualini, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.008 · Cited by 864
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695 · cited 1×
“In mice, HRG promoted antitumor immune responses and normalization of the vessel network (86).”
BackgroundKitamura, T., Qian, B.-Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Li, J., & Pollard, J. W. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141836 · Cited by 651
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651
Mantovani, A. (2009) · Nature · doi:10.1038/457036b · Cited by 643
Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.029 · Cited by 638 · cited 1×
“It is also known that in oxidative stress conditions, p21 interacts with Nrh2 domain of Nrf2, upregulating Nrf2-mediated antioxidant response (151).”
BackgroundTakeda, N., O'Dea, E. L., Doedens, A., Kim, J.-W., Weidemann, A., Stockmann, C., Asagiri, M., Simon, M. C., Hoffmann, A., & Johnson, R. S. (2010) · Genes & Development · doi:10.1101/gad.1881410 · Cited by 623
Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjällman, A. H. M., Ballmer-Hofer, K., & Schwendener, R. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603240 · Cited by 623
The interaction of anticancer therapies with tumor-associated macrophages
Mantovani, A., & Allavena, P. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150295 · Cited by 616
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Komohara, Y., Fujiwara, Y., Ohnishi, K., & Takeya, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.009 · Cited by 612
Georgoudaki, A.-M., Prokopec, K. E., Boura, V. F., Hellqvist, E., Sohn, S., Östling, J., Dahan, R., Harris, R. A., Rantalainen, M., Klevebring, D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.084 · Cited by 609
Butowski, N., Colman, H., De Groot, J. F., Omuro, A. M., Nayak, L., Wen, P. Y., Cloughesy, T. F., Marimuthu, A., Haidar, S., Perry, A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov245 · Cited by 593
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Soria, G., & Ben-Baruch, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.018 · Cited by 593
Qin, L., Liu, Y., Wang, T., Wei, S.-J., Block, M. L., Wilson, B., Liu, B., & Hong, J.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307657200 · Cited by 574
Zhang, Y., Choksi, S., Chen, K., Pobezinskaya, Y., Linnoila, I., & Liu, Z.-G. (2013) · Cell Research · doi:10.1038/cr.2013.75 · Cited by 573
Chi, H., Barry, S. P., Roth, R. J., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 569
Xu, J., Escamilla, J., Mok, S., David, J., Priceman, S., West, B., Bollag, G., McBride, W., & Wu, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3981 · Cited by 569
Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Ying, C., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 569
Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z.-H., & Miyamoto, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00895-x · Cited by 560
Vonderheide, R. H., Flaherty, K. T., Khalil, M., Stumacher, M. S., Bajor, D. L., Hutnick, N. A., Sullivan, P., Mahany, J. J., Gallagher, M., Kramer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3311 · Cited by 513
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Gupta, A., Probst, H. C., Vuong, V., Landshammer, A., Muth, S., Yagita, H., Schwendener, R., Pruschy, M., Knuth, A., & van den Broek, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200563 · Cited by 446
Pienta, K. J., Machiels, J.-P., Schrijvers, D., Alekseev, B., Shkolnik, M., Crabb, S. J., Li, S., Seetharam, S., Puchalski, T. A., Takimoto, C., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9869-8 · Cited by 412
TLR9 as a key receptor for the recognition of DNA☆
KUMAGAI, Y., TAKEUCHI, O., & AKIRA, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.12.004 · Cited by 387
Redox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377
Strachan, D. C., Ruffell, B., Oei, Y., Bissell, M. J., Coussens, L. M., Pryer, N., & Daniel, D. (2013) · OncoImmunology · doi:10.4161/onci.26968 · Cited by 376
Zhang, W., Zhu, X.-D., Sun, H.-C., Xiong, Y.-Q., Zhuang, P.-Y., Xu, H.-X., Kong, L.-Q., Wang, L., Wu, W.-Z., & Tang, Z.-Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 374
Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
Salojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M., Platt, K. A., & Oravecz, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1899 · Cited by 337
Lehenkari, P. P., Kellinsalmi, M., Näpänkangas, J. P., Ylitalo, K. V., Mönkkönen, J., Rogers, M. J., Azhayev, A., Väänänen, H. K., & Hassinen, I. E. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12222-5 · Cited by 333
Melani, C., Sangaletti, S., Barazzetta, F. M., Werb, Z., & Colombo, M. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1882 · Cited by 329
Hussain, S. F., Kong, L.-Y., Jordan, J., Conrad, C., Madden, T., Fokt, I., Priebe, W., & Heimberger, A. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1243 · Cited by 314
Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
Kalbasi, A., Komar, C., Tooker, G. M., Liu, M., Lee, J. W., Gladney, W. L., Ben-Josef, E., & Beatty, G. L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0870 · Cited by 305
Gazzaniga, S., Bravo, A. I., Guglielmotti, A., van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., & Wainstok, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700827 · Cited by 302
Radiation and immunotherapy: a synergistic combination
Kalbasi, A., June, C. H., Haas, N., & Vapiwala, N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69219 · Cited by 284
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
Zhang, J., Patel, L., & Pienta, K. J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.009 · Cited by 261
Tsai, C.-S., Chen, F.-H., Wang, C.-C., Huang, H.-L., Jung, S.-M., Wu, C.-J., Lee, C.-C., McBride, W. H., Chiang, C.-S., & Hong, J.-H. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.041 · Cited by 257
TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy
Shiao, S. L., Ruffell, B., DeNardo, D. G., Faddegon, B. A., Park, C. C., & Coussens, L. M. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0232 · Cited by 253
Choi, S., Aid, S., Kim, H., Jackson, S. H., & Bosetti, F. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07572.x · Cited by 222
Stafford, J. H., Hirai, T., Deng, L., Chernikova, S. B., Urata, K., West, B. L., & Brown, J. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov272 · Cited by 221
Kohchi, C., Inagawa, H., Nishizawa, T., & Soma, G. (2009) · PubMed · Cited by 220
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
D’Incalci, M., Badri, N., Galmarini, C. M., & Allavena, P. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.149 · Cited by 218
Brana, I., Calles, A., LoRusso, P. M., Yee, L. K., Puchalski, T. A., Seetharam, S., Zhong, B., de Boer, C. J., Tabernero, J., & Calvo, E. (2015) · Targeted Oncology · doi:10.1007/s11523-014-0320-2 · Cited by 216
Ying, H., Kang, Y., Zhang, H., Zhao, D., Xia, J., Lu, Z., Wang, H., Xu, F., & Shi, L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402088 · Cited by 213
Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies
Singh, S., & Gupta, A. K. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1654-4 · Cited by 212
Teresa Pinto, A., Laranjeiro Pinto, M., Patrícia Cardoso, A., Monteiro, C., Teixeira Pinto, M., Filipe Maia, A., Castro, P., Figueira, R., Monteiro, A., Marques, M., et al. (2016) · Scientific Reports · doi:10.1038/srep18765 · Cited by 209
Cancer‐promoting tumor‐associated macrophages: New vistas and open questions
Mantovani, A., Germano, G., Marchesi, F., Locatelli, M., & Biswas, S. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141894 · Cited by 207
Claasen, H. H. V. R., Kluin, P. M., & Fleuren, G. J. (1992) · PubMed · Cited by 201
Macrophage-based cell therapies: The long and winding road
Lee, S., Kivimäe, S., Dolor, A., & Szoka, F. C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.018 · Cited by 198
Rodel, F., Frey, B., Gaipl, U., Keilholz, L., Fournier, C., Manda, K., Schollnberger, H., Hildebrandt, G., & Rodel, C. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800099866 · Cited by 194
Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice
Seifert, L., Werba, G., Tiwari, S., Giao Ly, N. N., Nguy, S., Alothman, S., Alqunaibit, D., Avanzi, A., Daley, D., Barilla, R., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.070 · Cited by 190
NADPH Oxidases Are Essential for Macrophage Differentiation
Xu, Q., Choksi, S., Qu, J., Jang, J., Choe, M., Banfi, B., Engelhardt, J. F., & Liu, Z.-G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731216 · Cited by 184
Meng, Y., Beckett, M. A., Liang, H., Mauceri, H. J., van Rooijen, N., Cohen, K. S., & Weichselbaum, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2995 · Cited by 181
Unique features of trabectedin mechanism of action
Larsen, A. K., Galmarini, C. M., & D’Incalci, M. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2918-1 · Cited by 172
Protective roles of cytokines against radiation: Induction of mitochondrial MnSOD
Wong, G. H. W. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00029-4 · Cited by 171
Interferon-Regulatory Factors Determine Macrophage Phenotype Polarization
Günthner, R., & Anders, H.-J. (2013) · Mediators of Inflammation · doi:10.1155/2013/731023 · Cited by 168
Ding, L., Liang, G., Yao, Z., Zhang, J., Liu, R., Chen, H., Zhou, Y., Wu, H., Yang, B., & He, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.5541 · Cited by 165
Fritz, J. M., Tennis, M. A., Orlicky, D. J., Lin, H., Ju, C., Redente, E. F., Choo, K. S., Staab, T. A., Bouchard, R. J., Merrick, D. T., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00587 · Cited by 161
MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages
Huang, C., Liu, X.-J., QunZhou, Xie, J., Ma, T.-T., Meng, X.-M., & Li, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.009 · Cited by 160
Dewan, M. Z., Vanpouille‐Box, C., Kawashima, N., DiNapoli, S., Babb, J. S., Formenti, S. C., Adams, S., & Demaria, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0984 · Cited by 160
Sun, L., Chen, B., Jiang, R., Li, J., & Wang, B. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2016.11.002 · Cited by 159
ROS sets the stage for macrophage differentiation
Covarrubias, A., Byles, V., & Horng, T. (2013) · Cell Research · doi:10.1038/cr.2013.88 · Cited by 150
Wunderlich, R., Ernst, A., Rödel, F., Fietkau, R., Ott, O. J., Lauber, K., Frey, B., & Gaipl, U. S. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12344 · Cited by 148
Jassar, A. S., Suzuki, E., Kapoor, V., Sun, J., Silverberg, M. B., Cheung, L., Burdick, M. D., Strieter, R. M., Ching, L., Kaiser, L. R., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1658 · Cited by 148
ATM and ATR: Sensing DNA damage
Yang, J. J., Xu, Z., Huang, Y., Hamrick, H. E., Duerksen-Hughes, P. J., & Yu, Y. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i2.155 · Cited by 148
Redox regulation of NF ‐κB p50 and M1 polarization in microglia
Taetzsch, T., Levesque, S., McGraw, C., Brookins, S., Luqa, R., Bonini, M. G., Mason, R. P., Oh, U., & Block, M. L. (2014) · Glia · doi:10.1002/glia.22762 · Cited by 147
Induced PD-L1 Expression Mediates Acquired Resistance to Agonistic Anti-CD40 Treatment
Zippelius, A., Schreiner, J., Herzig, P., & Müller, P. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0226 · Cited by 145
Buhtoiarov, I. N., Sondel, P. M., Wigginton, J. M., Buhtoiarova, T. N., Yanke, E. M., Mahvi, D. A., & Rakhmilevich, A. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03357.x · Cited by 143
He, C., Ryan, A. J., Murthy, S., & Carter, A. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410720 · Cited by 140
Nagai, T., Tanaka, M., Tsuneyoshi, Y., Xu, B., Michie, S. A., Hasui, K., Hirano, H., Arita, K., & Matsuyama, T. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0667-x · Cited by 134
A Novel STAT6 Inhibitor AS1517499 Ameliorates Antigen-Induced Bronchial Hypercontractility in Mice
Chiba, Y., Todoroki, M., Nishida, Y., Tanabe, M., & Misawa, M. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0163oc · Cited by 130
Frey, B., Hehlgans, S., Rödel, F., & Gaipl, U. S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.010 · Cited by 126
Pyonteck, S. M., Gadea, B. B., Wang, H.-W., Gocheva, V., Hunter, K. E., Tang, L. H., & Joyce, J. A. (2011) · Oncogene · doi:10.1038/onc.2011.337 · Cited by 126
p21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β
Rackov, G., Hernández-Jiménez, E., Shokri, R., Carmona‐Rodríguez, L., Mañes, S., Álvarez‐Mon, M., López‐Collazo, E., Martínez‐A, C., & Balomenos, D. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83404 · Cited by 119
Galletti, G., Scielzo, C., Barbaglio, F., Rodríguez, T. V., Riba, M., Lazarević, D., Cittaro, D., Simonetti, G., Ranghetti, P., Scarfò, L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.042 · Cited by 117
Hypoxic tumor cell radiosensitization through nitric oxide
Ridder, M. D., Verellen, D., Verovski, V. N., & Storme, G. A. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.015 · Cited by 116
Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
Crittenden, M. R., Cottam, B., Savage, T., Nguyen, C., Newell, P., & Gough, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039295 · Cited by 116
Okubo, M., Kioi, M., Nakashima, H., Sugiura, K., Mitsudo, K., Aoki, I., Taniguchi, H., & Tohnai, I. (2016) · Scientific Reports · doi:10.1038/srep27548 · Cited by 114
Cranial Irradiation Alters the Brain’s Microenvironment and Permits CCR2+ Macrophage Infiltration
Morganti, J. M., Jopson, T. D., Liu, S., Gupta, N. M., & Rosi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093650 · Cited by 111
Zollo, M., Dato, V. D., Spano, D., Martino, D. D., Liguori, L., Marino, N., Vastolo, V., Navas, L., Garrone, B., Mangano, G., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9473-5 · Cited by 111
Hodge, J. W., Guha, C., Neefjes, J., & Gulley, J. L. (2008) · PubMed · Cited by 108
Chen, N., Wei, M., Sun, Y., Li, F., Pei, H., Li, X., Su, S., He, Y., Wang, L., Shi, J., et al. (2013) · Small · doi:10.1002/smll.201300903 · Cited by 107
Prakash, H., Klug, F., Nadella, V., Mazumdar, V. B., Schmitz‐Winnenthal, H., & Umansky, L. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw007 · Cited by 107
Shen, L., Li, H., Shi, Y., Wang, D., Gong, J., Xun, J., Zhou, S., Xiang, R., & Tan, X. (2016) · Scientific Reports · doi:10.1038/srep30347 · Cited by 107
Lödermann, B., Wunderlich, R., Frey, S., Schorn, C., Stangl, S., Rödel, F., Keilholz, L., Fietkau, R., Gaipl, U. S., & Frey, B. (2012) · International Journal of Radiation Biology · doi:10.3109/09553002.2012.689464 · Cited by 100
Shan, Y., Jin, S., Liu, X., Liu, Y., & Liu, S. (2006) · Radiation and Environmental Biophysics · doi:10.1007/s00411-006-0076-x · Cited by 99
Weiss, J. M., Ridnour, L. A., Back, T., Hussain, S. P., He, P., Maciag, A. E., Keefer, L. K., Murphy, W. J., Harris, C. C., Wink, D. A., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100670 · Cited by 99
Edwards, J. P., & Emens, L. A. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.07.002 · Cited by 91
Epperly, M. W., Sikora, C. A., DeFilippi, S. J., Gretton, J. E., Bar‐Sagi, D., Archer, H., Carlos, T. M., Guo, H., & Greenberger, J. S. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.pm12014807 · Cited by 91
Scavenger Receptor-A–Targeted Leukocyte Depletion Inhibits Peritoneal Ovarian Tumor Progression
Bąk, S., Walters, J. J., Takeya, M., Conejo-Garcia, J. R., & Berwin, B. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4410 · Cited by 89
Wu, Q., Allouch, A., Paoletti, A., Leteur, C., Mirjolet, C., Martins, I., Voisin, L., Law, F., Dakhli, H., Mintet, E., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.91 · Cited by 88
The Metabolic Prospective and Redox Regulation of Macrophage Polarization
He, C., & Carter, A. B. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000371 · Cited by 77
Macrophage Susceptibility to Emactuzumab (RG7155) Treatment
Pradel, L. P., Ooi, C.-H., Romagnoli, S., Cannarile, M. A., Sade, H., Rüttinger, D., & Ries, C. H. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0157 · Cited by 77
Wu, Q., Allouch, A., Martins, I., Brenner, C., Modjtahedi, N., Deutsch, É., & Perfettini, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00613 · Cited by 76
Galmbacher, K., Heisig, M., Hotz, C., Wischhusen, J., Galmiche, A., Bergmann, B., Gentschev, I., Goebel, W., Rapp, U. R., & Fensterle, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009572 · Cited by 65
Meyer, I., Martinet, W., Schrijvers, D., Timmermans, J., Bult, H., & Meyer, G. R. Y. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0269-1 · Cited by 64
Dong, R., Gong, Y., Meng, W., Meng, Y. G., Zhu, H., Ying, M., He, Q., Cao, J., & Yang, B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.029 · Cited by 63
Liang, W. P., Kujawski, M., Wu, J., Lu, J., Herrmann, A., Loera, S., Yen, Y., Lee, F., Yu, H., Wen, W. X., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1486 · Cited by 62
Kim, H. S., & Asmis, R. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.020 · Cited by 60
Jihee Lee Kang, E. W. (2000) · Journal of Toxicology and Environmental Health · doi:10.1080/009841000156574 · Cited by 59
Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation
Shin, S. C., Lee, K., Kang, Y. M., Kim, K., Kim, C. S., Yang, K. H., Jin, Y.-W., Kim, C. S., & Kim, H. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.121 · Cited by 56
Lum, H. D., Buhtoiarov, I. N., Schmidt, B. E., Berke, G., Paulnock, D. M., Sondel, P. M., & Rakhmilevich, A. L. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02366.x · Cited by 53
Tsukimoto, M., Homma, T., Mutou, Y., & Kojima, S. (2009) · Radiation Research · doi:10.1667/rr1351.1 · Cited by 51
Chung, Y. W., Kim, H.-K., Kim, I. Y., Yim, M. B., & Chock, P. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264945 · Cited by 50
Sugino, N., Karube-Harada, A., Sakata, A., Takiguchi, S., & Kato, H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8771 · Cited by 50
Tsukimoto, M., Tamaishi, N., Homma, T., & Kojima, S. (2010) · Journal of Radiation Research · doi:10.1269/jrr.10002 · Cited by 49
Palma, M. D., Coukos, G., & Hanahan, D. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.019 · Cited by 43
Nowosielska, E. M., Cheda, A., Wrembel‐Wargocka, J., & Janiak, M. K. (2012) · Dose-Response · doi:10.2203/dose-response.12-018.nowosielska · Cited by 37
Jordan, M., & Waxman, D. J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.029 · Cited by 37
Trabectedin for the treatment of breast cancer
D’Incalci, M., & Zambelli, A. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1124086 · Cited by 36
Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation
Pinto, A. T., Pinto, M. L., Velho, S., Pinto, M. T., Cardoso, A. P., Figueira, R., Monteiro, A., Marques, M., Seruca, R., Barbosa, M. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160891 · Cited by 36
Parker, J. J., Jones, J. C., Strober, S., & Knox, S. J. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.03.008 · Cited by 34
Song, K., Kim, M., Kang, S.-M., Jung, S.-Y., Ahn, J., Woo, H., Nam, S. Y., Hwang, S., Ryu, S., & Song, J. Y. (2015) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.1068461 · Cited by 33
γ-Irradiation-induced DNA damage enhances NO production via NF-κB activation in RAW264.7 cells
Ibuki, Y., Mizuno, S., & Goto, R. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00385-3 · Cited by 32
TMC-264, a Novel Inhibitor of STAT6 Activation Produced by Phoma sp. TC 1674
Sakurai, M., NISHIO, M., Yamamoto, K., Okuda, T., Kawano, K., & Ohnuki, T. (2003) · The Journal of Antibiotics · doi:10.7164/antibiotics.56.513 · Cited by 32
Carbon-Ion-Induced Activation of the NF-κB Pathway
Hellweg, C. E., Baumstark‐Khan, C., Schmitz, C., Lau, P., Meier, M. M., Testard, I., Berger, T., & Reitz, G. (2011) · Radiation Research · doi:10.1667/rr2423.1 · Cited by 29
New tricks for metastasis-associated macrophages
Qian, B., & Pollard, J. W. (2012) · Breast Cancer Research · doi:10.1186/bcr3143 · Cited by 27
Kim, H. S., Tavakoli, S., Piefer, L. A., Nguyen, H. N., & Asmis, R. (2016) · Scientific Reports · doi:10.1038/srep34223 · Cited by 26
DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells
Fukuchi, K., Tomoyasu, S., Nakamaki, T., Tsuruoka, N., & Gomi, K. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00089-5 · Cited by 25
Enhancement of DNA Vaccine Potency Against Legumain
Šmahel, M., Dušková, M., Poláková, I., & Musil, J. (2014) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000040 · Cited by 23
Role of iNOS in Bystander Signaling Between Macrophages and Lymphoma Cells
Ghosh, S., Maurya, D. K., & Krishna, M. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.08.006 · Cited by 22
Hachiya, M., SHIMIZU, S., Osawa, Y., & Akashi, M. (1997) · Biochemical Journal · doi:10.1042/bj3280615 · Cited by 21
Fukuchi, K., Hagiwara, T., Nakamura, K., Ichimura, S., Tatsumi, K., & Gomi, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00198-5 · Cited by 19
Narang, H., & Krishna, M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21429 · Cited by 15
Ryu, Y., Lee, M.-H., Lee, J., Lee, J., Jang, S.-J., Kang, J., & Moon, E. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0114-055r · Cited by 12
Cited by
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
Sawant, D. V., Yano, H., Chikina, M., Zhang, Q., Liao, M., Liu, C., Callahan, D. J., Sun, Z., Sun, T., Tabib, T., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0346-9 · Cited by 543
Weng, Y.-S., Tseng, H.-Y., Chen, Y.-A., Shen, P.-C., Al Haq, A. T., Chen, L.-M., Tung, Y.-C., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 444
Metadata
- Authors
- Genard, G., Lucas, S., & Michiels, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-07-14
- Volume
- 8
- Pages
- 828-828
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2735818385
- Cited by
- 419
- References
- 151
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.